Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2024-05-17 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares the company purchased during the period from May 13, 2024, to May 17, 2024. This activity—the company buying back its own shares—is specifically covered by the definition for 'Transaction in Own Shares'. The filing code corresponding to this activity is POS (Transaction in Own Shares). Although it is a weekly report, the core subject matter dictates the classification over a general report type like IR or ER.
2024-05-17 Italian
Assemblea dei soci approva il Bilancio al 31.12.2023
AGM Information Classification · 98% confidence The document is a press release (COMUNICATO STAMPA) detailing the resolutions passed during the Shareholders' Meeting (Assemblea dei soci) of Svas Biosana S.p.A. held on May 15, 2024. The key resolutions include the approval of the financial statements (bilancio di esercizio) for the year ended December 31, 2023, the decision to distribute a dividend (€ 0.30 per share), and the appointment of the Board of Directors and Statutory Auditors. Since the document primarily announces the results and decisions made at the Annual General Meeting (AGM) regarding the approval of the annual accounts and dividend distribution, it strongly aligns with the content covered by an AGM-related filing. While it contains financial results (which might suggest ER or IR), the context is explicitly the meeting where these were approved. The final paragraph mentions that the full documentation, including the minutes (verbale dell'Assemblea), will be made available, confirming this is the announcement of the meeting's outcome. Therefore, AGM-R (AGM Information) is the most appropriate classification.
2024-05-15 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares the company purchased during the period from May 6, 2024, to May 10, 2024. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS. Although it is a weekly report, the core subject is the share repurchase program execution, making POS more specific than a general Regulatory Filing (RNS). The document length is substantial enough (6158 chars) that it is the report itself, not just an announcement of a report.
2024-05-10 Italian
Ricavi consolidati al 31 marzo 2024
Earnings Release Classification · 98% confidence The document is a press release ('COMUNICATO STAMPA') from Svas Biosana S.p.A. dated May 9, 2024. The subject ('Oggetto') is 'Ricavi consolidati al 31 marzo 2024' (Consolidated revenues as of March 31, 2024). It explicitly states that the Board of Directors examined the consolidated revenue data for the first quarter (1Q 2024), showing revenues of Euro 28.6 million (+8.3% YoY). This content—the initial announcement of key financial results for a specific period (Q1)—perfectly matches the definition of an Earnings Release (ER). It is not a comprehensive report (IR or 10-K) nor is it merely an announcement of a report's publication (RPA), as it contains the actual summarized results. Q1 2024
2024-05-09 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares repurchased by Svas Biosana S.p.A. between April 29, 2024, and May 3, 2024. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2024-05-03 Italian
Convocazione Assemblea azionisti e messa a disposizione documenti
AGM Information Classification · 100% confidence The document is an official communication (Informazione Regolamentata) from SVAS BIOSANA S.p.A. dated April 30, 2024. The subject ('Oggetto') and the main headline ('PUBBLICAZIONE DELL'AVVISO DI CONVOCAZIONE ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI E DEPOSITO DELLA DOCUMENTAZIONE') clearly indicate that the company is announcing the formal convocation of an Ordinary and Extraordinary Shareholders' Meeting (Assemblea degli Azionisti) scheduled for May 15/16, 2024. The agenda includes the approval of the 2023 financial statements, dividend distribution, and the appointment/renewal of the Board of Directors and Statutory Auditors. This document serves to formally notify shareholders of the meeting details and the availability of related documentation, which is the primary function of an AGM notice or related preparatory material. Since it is the formal notice/convocation document itself, and not just a presentation (IP) or a vote result (DVA), the most appropriate classification is AGM-R (AGM Information), as it directly relates to the upcoming Annual General Meeting proceedings.
2024-04-30 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.